A few studies on LEV’s ineffectiveness have been reported in patients with SeLIE associated with PRRT2 mutations [29, 30], and the mechanism of LEV’s inefficacy or exacerbation of PRRT2-related epilepsy is unclear. Here, PRRT2 is linked to epilepsy.